News Conference News ESC 2020 Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF Michael O'Riordan August 31, 2020
News Conference News ESC 2020 Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC Shelley Wood August 31, 2020
News Daily News GATEWAY at 3 Years: Bariatric Surgery Continues to Reduce Need for Antihypertensive Drugs L.A. McKeown August 31, 2020
News Daily News US Mortality Rates for CVD Have Stalled as Racial Disparities Widen Yael L. Maxwell August 19, 2020
News Daily News CV Prevention Meds Underused in Hispanic, Latinx PAD Patients L.A. McKeown August 12, 2020
News Features COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions Shelley Wood July 20, 2020
News Daily News Thrombus Burden Greater in STEMI Patients With COVID-19 Michael O'Riordan July 20, 2020
News Daily News Higher Risk of HF After ACS for Women Previously on Beta-blockers Michael O'Riordan July 16, 2020
News Daily News PAD Patients Undertreated With Statins Despite Elevated CV Risk L.A. McKeown July 13, 2020
News Daily News Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly Michael O'Riordan July 06, 2020
News Daily News Rural-Urban Gap Widens for Cardiometabolic Health Disparities Michael O'Riordan June 22, 2020
News Daily News Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension L.A. McKeown June 08, 2020
News Daily News Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades Yael L. Maxwell May 28, 2020
News Daily News No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests Yael L. Maxwell May 21, 2020
News Daily News More Evidence of Lower Fracture Risk With DOACs Versus Warfarin Todd Neale May 19, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Features COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention Michael O'Riordan April 24, 2020
News Daily News ACE Inhibitors/ARBs Safe, Possibly Protective in Hypertensive COVID-19 Patients Caitlin E. Cox April 24, 2020
News Conference News ACC 2020 New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy L.A. McKeown April 02, 2020
News Daily News ACE Inhibitors, ARBs, and COVID-19: New Insights, Advice Yael L. Maxwell March 26, 2020